Three of WI Harper’s portfolio companies have made the 2019Venture50 preliminary evaluation list: EdiGene, Histo Pathology, CreditX Source: WI Harper Group The 2019Venture50 preliminary evaluation list was just released. Since its launch earlier this April, Venture50 has attracted 7000+ projects to…
WI Harper-backed Neuracle Technology Co., Ltd. has officially announced the completion of a RMB 60 million financing round. To date, Neuracle has completed three rounds of financing, with a total financing scale exceeding Rmb 100million. This round of investment was led by…
In the past year, despite weaknesses in the broader venture landscape, WI Harper Group has experienced a particularly special and successful period. Our portfolio has demonstrated significant growth across various innovative sectors. Most notably, Alpha Ring, a provider of nuclear fusion-enabled…
In the past year, despite weaknesses in the broader venture landscape, WI Harper Group has experienced a particularly special and successful period. Our portfolio has demonstrated significant growth across various innovative sectors. Most notably, Alpha Ring, a provider of nuclear fusion-enabled…
We are pleased to announce that WI Harper Group-backed Roadzen Inc., a global leader in AI-driven auto insurance, has taken on a new role as a founding member of the AI Alliance. This alliance comprises over 50 top organizations across…
We are very happy to bring you the exciting news that WI Harper-backed Roadzen and Vahanna Tech Edge Acquisition I Corp. successfully completed their business combination on September 20, 2023. This marks an important milestone in the evolution of insurance…
RWDC Industries, a biotechnology company developing biopolymer material solutions, and Lummus Technology, a global provider of process technologies and value-driven energy solutions, signed a memorandum of understanding (MOU) to cooperate on global PHA deployment initiatives. The signing ceremony took place…
Neuracle, a leading brain-computer interface technology company based in Beijing, has successfully completed its Series C round of financing led by Green Pine Capital Partners. Early backer WI Harper participated in the round along with other existing investors. Founded in…
[vc_row][vc_column][vc_column_text] WI Harper Group | August 17, 2022 | Source: GrubMarket GrubMarket announces the acquisition of Albuquerque, New Mexico, and El Paso, Texas-based Quality Fruit & Vegetable Co. (QF&V), a highly respected fresh produce company that provides the highest quality…
[vc_row][vc_column][vc_column_text] WI Harper Group | June 8, 2022 | YesHealth Group, a vertical farming technology company, was recognized by the World Economic Forum (WEF) as part of its 2022 class of most promising Technology Pioneers. A luncheon was held at…
50 California Street Suite #2580 San Francisco, CA 94111 United States of America Tel: (415) 397-6200 Fax: (415) 397-6280
806 Tower A Pacific Century Place Beijing 100027 People’s Republic of China Tel: (86-10) 6539-1366 Fax: (86-10) 6539-1367
10F-2 Ruentex Banking Tower 76 Tun Hua South Road Sec.2 Taipei Taiwan Tel: (886-2) 2755-6033 Fax: (886-2) 2709-2127
Resvent Medical is a Shenzhen, China-based medical device and solution company focused on medical respiration & ventilation field, with its core management team having spun out of Mindray’s hospitals respiratory division, with over a decade of experience in homecare devices, clinical respiratory healthcare, intelligent information system, related consumable & accessories and value added services, and capable of building a globally competitive respiratory player – i.e. the RESMED of China.
